Recent Posts
- FDA Approves Harm Reduction Therapeutics’ Over-the-Counter Opioid Overdose Reversal Medication
- Second Circuit Court Upholds Purdue Pharma’s Plan of Reorganization on Appeal
- Purdue Pharma L.P. to Provide Funding Opportunities for Investigator-Initiated Research to Examine Opioid Overdose Reversal Using Nalmefene HCl Injection
- Harm Reduction Therapeutics to Receive Additional Funding for its Low-Cost Over-the-Counter Opioid Overdose Reversal Medication from Purdue Pharma
- FDA Grants Priority Review for Nalmefene Prefilled Syringe for the Treatment of Known or Suspected Opioid Overdose
Archives
- August 2023
- May 2023
- March 2023
- January 2023
- November 2022
- June 2022
- March 2022
- February 2022
- December 2021
- September 2021
- July 2021
- June 2021
- March 2021
- October 2020
- August 2020
- June 2020
- March 2020
- February 2020
- September 2019
- August 2019
- July 2019
- June 2019
- April 2019
- March 2019
- February 2019
- January 2019
- October 2018
- September 2018
- August 2018
- February 2018
- January 2018